{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:07:04Z","timestamp":1793210824759,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","award":["95-02-159-32345"],"award-info":[{"award-number":["95-02-159-32345"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.critrevonc.2020.102945","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T03:11:35Z","timestamp":1587525095000},"page":"102945","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Lymphoma in the setting of autoimmune diseases: A review of association and mechanisms"],"prefix":"10.1016","volume":"150","author":[{"given":"Shaghayegh","family":"Khanmohammadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsima","family":"Shabani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3746-7371","authenticated-orcid":false,"given":"Mohammadreza","family":"Tabary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Rayzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3836-1827","authenticated-orcid":false,"given":"Nima","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.critrevonc.2020.102945_bib0005","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/neup.12175","article-title":"CNS intravascular large cell lymphoma in a patient with autoimmune hemolytic anemia","volume":"35","author":"Alexandrescu","year":"2015","journal-title":"Neuropathology"},{"issue":"2","key":"10.1016\/j.critrevonc.2020.102945_bib0010","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1586\/eci.11.88","article-title":"Etiology of autoimmune disease: past, present and future","volume":"8","author":"Alzabin","year":"2012","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.critrevonc.2020.102945_bib0015","unstructured":"Andrew W. Gibson JCEJW, Robert P.K. The Role of IL-10 in Autoimmune Pathology."},{"issue":"2","key":"10.1016\/j.critrevonc.2020.102945_bib0020","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s12026-016-8885-8","article-title":"Correlation between systemic lupus erythematosus and malignancies: a cross-sectional population-based study","volume":"65","author":"Azrielant","year":"2017","journal-title":"Immunol. Res."},{"key":"10.1016\/j.critrevonc.2020.102945_bib0025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.semcancer.2013.12.001","article-title":"Lymphoma development in patients with autoimmune and inflammatory disorders--what are the driving forces?","volume":"24","author":"Baecklund","year":"2014","journal-title":"Semin. Cancer Biol."},{"issue":"2","key":"10.1016\/j.critrevonc.2020.102945_bib0030","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1046\/j.1365-2141.2001.02749.x","article-title":"Diffuse large B-cell non-Hodgkin's lymphoma in a patient with autoimmune lymphoproliferative syndrome","volume":"113","author":"Boulanger","year":"2001","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.critrevonc.2020.102945_bib0035","first-page":"336","article-title":"Impact of interleukin-6 in hematological malignancies","volume":"40","author":"Burger","year":"2013","journal-title":"Transfusion medicine and hemotherapy: offizielles Organ der Deutschen Gesellschaft fur Transfusintitle>Transfusion medicine and hemotherapy: offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie."},{"issue":"4","key":"10.1016\/j.critrevonc.2020.102945_bib0040","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/MPH.0b013e318236c4e4","article-title":"Autoimmune hemolytic anemia and immune thrombocytopenia as unusual presentations of childhood Hodgkin lymphoma: a case report and review of the literature","volume":"34","author":"Cecinati","year":"2012","journal-title":"J. Pediatr. Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2020.102945_bib0045","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2141.2011.08624.x","article-title":"TNFAIP3 abnormalities in MALT lymphoma with autoimmunity","volume":"154","author":"Chanudet","year":"2011","journal-title":"Br. J. Haematol."},{"issue":"7","key":"10.1016\/j.critrevonc.2020.102945_bib0050","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/sj.gene.6364420","article-title":"Differential expression in lupus-associated IL-10 promoter single-nucleotide polymorphisms is mediated by poly(ADP-ribose) polymerase-1","volume":"8","author":"Chung","year":"2007","journal-title":"Genes Immun."},{"issue":"1","key":"10.1016\/j.critrevonc.2020.102945_bib0055","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ygeno.2011.03.007","article-title":"A search for overlapping genetic susceptibility loci between non-Hodgkin lymphoma and autoimmune diseases","volume":"98","author":"Conde","year":"2011","journal-title":"Genomics"},{"issue":"3","key":"10.1016\/j.critrevonc.2020.102945_bib0060","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1568-9972(03)00006-5","article-title":"The epidemiology of autoimmune diseases","volume":"2","author":"Cooper","year":"2003","journal-title":"Autoimmun. Rev."},{"issue":"4","key":"10.1016\/j.critrevonc.2020.102945_bib0065","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2141.2004.05353.x","article-title":"Effect of IL-6 promoter polymorphism on incidence and outcome in Hodgkin\u2019s lymphoma","volume":"128","author":"Cordano","year":"2005","journal-title":"Br. J. Haematol."},{"issue":"3-4","key":"10.1016\/j.critrevonc.2020.102945_bib0070","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/10428199709051774","article-title":"Interleukin-10 in non-Hodgkin\u2019s lymphoma","volume":"26","author":"Cortes","year":"1997","journal-title":"Leuk. Lymphoma"},{"issue":"10","key":"10.1016\/j.critrevonc.2020.102945_bib0075","first-page":"1884","article-title":"Autoimmune disease is a risk factor for the development of non-Hodgkin\u2019s lymphoma","volume":"32","author":"Cuttner","year":"2005","journal-title":"J. Rheumatol."},{"issue":"8","key":"10.1016\/j.critrevonc.2020.102945_bib0080","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.3109\/10428194.2012.660628","article-title":"Autoimmune hemolytic anemia and autoimmune thrombocytopenia at diagnosis and during follow-up of Hodgkin lymphoma","volume":"53","author":"Dimou","year":"2012","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.critrevonc.2020.102945_bib0085","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/535738","article-title":"Epstein-Barr virus in systemic autoimmune diseases","volume":"2013","author":"Draborg","year":"2013","journal-title":"Clin. Dev. Immunol."},{"issue":"8","key":"10.1016\/j.critrevonc.2020.102945_bib0090","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1182\/blood-2007-10-119974","article-title":"Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium","volume":"111","author":"Ekstrom Smedby","year":"2008","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.critrevonc.2020.102945_bib0095","doi-asserted-by":"crossref","first-page":"600","DOI":"10.2353\/ajpath.2008.071008","article-title":"Sex differences in autoimmune disease from a pathological perspective","volume":"173","author":"Fairweather","year":"2008","journal-title":"Am. J. Pathol."},{"issue":"7","key":"10.1016\/j.critrevonc.2020.102945_bib0100","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/annonc\/mdu144","article-title":"Hodgkin lymphoma after autoimmune diseases by age at diagnosis and histological subtype","volume":"25","author":"Fallah","year":"2014","journal-title":"Ann. Oncol."},{"issue":"10","key":"10.1016\/j.critrevonc.2020.102945_bib0105","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1093\/annonc\/mdu365","article-title":"Autoimmune diseases associated with non-Hodgkin lymphoma: a nationwide cohort study","volume":"25","author":"Fallah","year":"2014","journal-title":"Ann. Oncol."},{"issue":"11","key":"10.1016\/j.critrevonc.2020.102945_bib0110","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.leukres.2009.05.008","article-title":"Autoimmunity and lymphoma: is mantle cell lymphoma a mistake of the receptor editing mechanism?","volume":"33","author":"Garcia-Munoz","year":"2009","journal-title":"Leuk. Res."},{"issue":"2","key":"10.1016\/j.critrevonc.2020.102945_bib0115","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1080\/10408363.2017.1422692","article-title":"Hodgkin\u2019s lymphoma and its association with EBV and HIV infection","volume":"55","author":"Grewal","year":"2018","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"issue":"12","key":"10.1016\/j.critrevonc.2020.102945_bib0120","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1136\/jcp.2007.051953","article-title":"HIV infection and lymphoma","volume":"60","author":"Grogg","year":"2007","journal-title":"J. Clin. Pathol."},{"issue":"3-4","key":"10.1016\/j.critrevonc.2020.102945_bib0125","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3109\/10428199509059623","article-title":"Autoimmune phenomena in non-Hodgkin\u2019s lymphoma","volume":"18","author":"Gronbaek","year":"1995","journal-title":"Leuk. Lymphoma"},{"issue":"9","key":"10.1016\/j.critrevonc.2020.102945_bib0130","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1182\/blood.V92.9.3018","article-title":"Somatic Fas mutations in non-Hodgkin\u2019s lymphoma: association with extranodal disease and autoimmunity","volume":"92","author":"Gronbaek","year":"1998","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.critrevonc.2020.102945_bib0135","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/COH.0b013e32834577b3","article-title":"Th17 cells and regulatory T cells in elite control over HIV and SIV","volume":"6","author":"Hartigan-O\u2019Connor","year":"2011","journal-title":"Curr. Opin. HIV AIDS"},{"issue":"1","key":"10.1016\/j.critrevonc.2020.102945_bib0140","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2016.123","article-title":"Familial associations of lymphoma and myeloma with autoimmune diseases","volume":"7","author":"Hemminki","year":"2017","journal-title":"Blood Cancer J."},{"issue":"7","key":"10.1016\/j.critrevonc.2020.102945_bib0145","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2183\/pjab.86.717","article-title":"Interleukin 6 in autoimmune and inflammatory diseases: a personal memoir","volume":"86","author":"Hirano","year":"2010","journal-title":"Proc. Jpn. Acad., Ser. B, Phys. Biol. Sci."},{"key":"10.1016\/j.critrevonc.2020.102945_bib0150","article-title":"Hemophagocytic Lymphohistiocytosis in a patient with classical hodgkin lymphoma","volume":"2016","author":"Hyun","year":"2016","journal-title":"Case Rep. Hematol."},{"key":"10.1016\/j.critrevonc.2020.102945_bib0155","first-page":"1","article-title":"Autoimmune manifestations associated with lymphoma: characteristics and outcome in a multicenter retrospective cohort study","author":"Jachiet","year":"2017","journal-title":"Leuk. Lymphoma"},{"issue":"4","key":"10.1016\/j.critrevonc.2020.102945_bib0160","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/ejh.12157","article-title":"Primary autoimmune myelofibrosis (MF) with high-grade peripheral T-cell lymphoma (PTCL) NOS","volume":"91","author":"Jain","year":"2013","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.critrevonc.2020.102945_bib0165","doi-asserted-by":"crossref","DOI":"10.1002\/hon.2498","article-title":"Presence of autoimmune disease affects not only risk but also survival in patients with B-cell non-Hodgkin lymphoma","author":"Kleinstern","year":"2018","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.critrevonc.2020.102945_bib0170","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2015.00051","article-title":"The Link between Autoimmunity and Lymphoma: Does NOTCH Signaling Play a Contributing Role?","volume":"5","author":"Kuksin","year":"2015","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2020.102945_bib0175","doi-asserted-by":"crossref","first-page":"151","DOI":"10.12691\/ijcd-3-4-8","article-title":"The world incidence and prevalence of autoimmune diseases is increasing","volume":"3","author":"Lerner","year":"2015","journal-title":"Int J Celiac Dis."},{"key":"10.1016\/j.critrevonc.2020.102945_bib0180","series-title":"Cellular and Molecular Immunology","author":"Lichtman","year":"2017"},{"issue":"4","key":"10.1016\/j.critrevonc.2020.102945_bib0185","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0950-3536(05)80175-1","article-title":"Chronic lymphoproliferative disorders: classification and diagnosis","volume":"6","author":"Litz","year":"1993","journal-title":"Baillieres Clin. Haematol."},{"issue":"10","key":"10.1016\/j.critrevonc.2020.102945_bib0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078756","article-title":"Influence of Atg5 mutation in SLE depends on functional IL-10 genotype","volume":"8","author":"Lopez","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2020.102945_bib0195","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1749-6632.2010.05877.x","article-title":"B cell receptor editing in tolerance and autoimmunity","volume":"1217","author":"Luning Prak","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"3","key":"10.1016\/j.critrevonc.2020.102945_bib0200","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/art.23267","article-title":"Autoimmune disease in individuals and close family members and susceptibility to non-Hodgkin\u2019s lymphoma","volume":"58","author":"Mellemkjaer","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.critrevonc.2020.102945_bib0205","series-title":"Apoptosis by Death Factor","author":"Nagata","year":"1997"},{"issue":"48","key":"10.1016\/j.critrevonc.2020.102945_bib0210","doi-asserted-by":"crossref","first-page":"14948","DOI":"10.1073\/pnas.1520861112","article-title":"Genetic polymorphism directs IL-6 expression in fibroblasts but not selected other cell types","volume":"112","author":"Noss","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.critrevonc.2020.102945_bib0215","series-title":"Globocan Worldwide Fact Sheet 2018","author":"Organization WH","year":"2019"},{"issue":"1","key":"10.1016\/j.critrevonc.2020.102945_bib0220","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/v8010005","article-title":"HTLV-1, immune response and autoimmunity","volume":"8","author":"Quaresma","year":"2015","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.critrevonc.2020.102945_bib0225","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1172\/JCI78088","article-title":"Mechanisms of human autoimmunity","volume":"125","author":"Rosenblum","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.critrevonc.2020.102945_bib0230","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cyto.2016.11.010","article-title":"Interleukin-10: Role in increasing susceptibility and pathogenesis of rheumatic fever\/rheumatic heart disease","volume":"90","author":"Sharma","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.critrevonc.2020.102945_bib0235","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/725219","article-title":"Incidence patterns and outcomes for hodgkin lymphoma patients in the United States","volume":"2011","author":"Shenoy","year":"2011","journal-title":"Adv. Hematol."},{"issue":"1","key":"10.1016\/j.critrevonc.2020.102945_bib0240","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/jnci\/djj004","article-title":"Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype","volume":"98","author":"Smedby","year":"2006","journal-title":"J. Natl. Cancer Inst."},{"issue":"11","key":"10.1016\/j.critrevonc.2020.102945_bib0245","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1158\/1055-9965.EPI-06-0300","article-title":"Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics","volume":"15","author":"Smedby","year":"2006","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"8","key":"10.1016\/j.critrevonc.2020.102945_bib0250","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s10067-015-2881-6","article-title":"Genetics of serum concentration of IL-6 and TNFalpha in systemic lupus erythematosus and rheumatoid arthritis: a candidate gene analysis","volume":"34","author":"Solus","year":"2015","journal-title":"Clin. Rheumatol."},{"issue":"6","key":"10.1016\/j.critrevonc.2020.102945_bib0255","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/0092-8674(93)90326-L","article-title":"Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor family","volume":"75","author":"Suda","year":"1993","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.critrevonc.2020.102945_bib0260","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3109\/08820139.2014.989328","article-title":"CD38 and interleukin 6 gene polymorphism in egyptians with diffuse large B-cell lymphoma (DLBCL)","volume":"44","author":"Talaat","year":"2015","journal-title":"Immunol. Invest."},{"issue":"9","key":"10.1016\/j.critrevonc.2020.102945_bib0265","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.7150\/ijbs.4666","article-title":"Targeting interleukin-6: all the way to treat autoimmune and inflammatory diseases","volume":"8","author":"Tanaka","year":"2012","journal-title":"Int. J. Biol. Sci."},{"issue":"1-2","key":"10.1016\/j.critrevonc.2020.102945_bib0270","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.beha.2016.07.006","article-title":"Marginal zone lymphoma: associated autoimmunity and auto-immune disorders","volume":"30","author":"Teixeira Mendes","year":"2017","journal-title":"Best Pract. Res. Clin. Haematol."},{"issue":"4","key":"10.1016\/j.critrevonc.2020.102945_bib0275","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jaut.2007.07.009","article-title":"Autoimmunity and pathophysiology","volume":"29","author":"Tsonis","year":"2007","journal-title":"J. Autoimmun."},{"issue":"4","key":"10.1016\/j.critrevonc.2020.102945_bib0280","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.autrev.2010.11.001","article-title":"Excess of autoimmune and chronic inflammatory disorders in patients with lymphoma compared with all cancer patients: a cancer registry-based analysis in the south of the Netherlands","volume":"10","author":"van de Schans","year":"2011","journal-title":"Autoimmun. Rev."},{"issue":"6","key":"10.1016\/j.critrevonc.2020.102945_bib0285","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00296-002-0229-4","article-title":"Malignant lymphoma-associated autoimmune diseases--a descriptive epidemiological study","volume":"22","author":"Varoczy","year":"2002","journal-title":"Rheumatol. Int."},{"issue":"5","key":"10.1016\/j.critrevonc.2020.102945_bib0290","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1389821","article-title":"Interleukin 10 (IL10) proximal promoter polymorphisms beyond clinical response in classical Hodgkin lymphoma: exploring the basis for the genetic control of the tumor microenvironment","volume":"7","author":"Vera-Lozada","year":"2018","journal-title":"Oncoimmunology"},{"issue":"6","key":"10.1016\/j.critrevonc.2020.102945_bib0295","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/aje\/kwu290","article-title":"Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci","volume":"181","author":"Wang","year":"2015","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.critrevonc.2020.102945_bib0300","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.3389\/fmicb.2018.01686","article-title":"HTLV-1-Mediated Epigenetic Pathway to Adult T-Cell Leukemia-Lymphoma","volume":"9","author":"Yamagishi","year":"2018","journal-title":"Front. Microbiol."},{"issue":"4","key":"10.1016\/j.critrevonc.2020.102945_bib0305","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/annrheumdis-2016-209815","article-title":"Incidence of autoimmune diseases in a nationwide HIV\/AIDS patient cohort in Taiwan, 2000\u20132012","volume":"76","author":"Yen","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.critrevonc.2020.102945_bib0310","doi-asserted-by":"crossref","first-page":"7684","DOI":"10.3390\/ijms15057684","article-title":"Different role of tumor necrosis factor-alpha polymorphism in non-Hodgkin lymphomas among Caucasian and Asian populations: a meta-analysis","volume":"15","author":"Zhai","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"1111","key":"10.1016\/j.critrevonc.2020.102945_bib0315","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/postgradmedj-2017-135441","article-title":"Association of interleukin-10 gene single nucleotide polymorphisms with rheumatoid arthritis in a Chinese population","volume":"94","author":"Zhang","year":"2018","journal-title":"Postgrad. Med. J."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842820300834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842820300834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:34:21Z","timestamp":1760902461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842820300834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":63,"alternative-id":["S1040842820300834"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2020.102945","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lymphoma in the setting of autoimmune diseases: A review of association and mechanisms","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2020.102945","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102945"}}